CA53846-2 - 0x000000000000751F

Males & Females of Non-Childbearing Potential

Eggwhite

* Stipend may pay up to reflected amount.
Start Date: 
November 14, 2026 - 2:00pm
End Date: 
January 13, 2027 - 11:30am

Study Details

Study Number: CA53846
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $15,750.00

Study Criteria

Age: 19 - 55
BMI: 18 - 29.49
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This marketed medication is approved to treat thyroid cancer.
Route of Administration: Oral
Blood Draws: 44

Study Schedule

Schedule Type: Long Term
Study Length: Two - 11 Nights Stays, 7 Returns & 1 Phone Call

Screening Dates:

Event Day Event Date
Monday 11/9/2026
Tuesday 11/10/2026
Wednesday 11/11/2026
Thursday 11/12/2026
Friday 11/13/2026
Saturday 11/14/2026

Doctor Exam Dates:

Event Day Event Date
Monday 11/9/2026
Tuesday 11/10/2026
Wednesday 11/11/2026
Thursday 11/12/2026
Friday 11/13/2026
Saturday 11/14/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Saturday 11/14/2026 2:00:00 PM Wednesday 11/25/2026 9:30:00 AM 1 Lincoln
Return Saturday 11/28/2026 7:30:00 AM Saturday 11/28/2026 9:15:00 AM 1 Lincoln
Return Wednesday 12/2/2026 7:30:00 AM Wednesday 12/2/2026 9:15:00 AM 1 Lincoln
Return Sunday 12/6/2026 7:30:00 AM Sunday 12/6/2026 9:15:00 AM 1 Lincoln
Check-In Sunday 12/13/2026 2:00:00 PM Thursday 12/24/2026 9:30:00 AM 2 Lincoln
Return Sunday 12/27/2026 7:30:00 AM Sunday 12/27/2026 9:15:00 AM 2 Lincoln
Return Thursday 12/31/2026 7:30:00 AM Thursday 12/31/2026 9:15:00 AM 2 Lincoln
Return Sunday 1/3/2027 7:30:00 AM Sunday 1/3/2027 9:15:00 AM 2 Lincoln
Return Monday 1/4/2027 7:30:00 AM Monday 1/4/2027 9:15:00 AM 2 Lincoln
Phone participant Wednesday 1/13/2027 11:30:00 AM 2 Lincoln